im guessing that pre bla fda meeting for accelerated approval for lvad and maybe also the pathway meeting for hlhs will happen relatively quickly after the gvhd resubmission is finalised, as they free up some bandwidth. so im thinking that submission could possibly come forward 6 months.
im wondering does silviu newspaper comment regarding fda and the data increase the possibility of a 2 month review.
either way, im not in a rush. as long as we get gvhd across the line
2024 Here we go again., page-605
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 98.5¢ | 95.5¢ | $193.0K | 194.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 752 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.5¢ | 365 | 2 |
View Market Depth
| Last trade - 09.44am 27/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable